Measuring the Frequency of Latent HIV-1 in Resting CD4⁺ T Cells Using a Limiting Dilution Coculture Assay
- PMID: 26714716
- DOI: 10.1007/978-1-4939-3046-3_16
Measuring the Frequency of Latent HIV-1 in Resting CD4⁺ T Cells Using a Limiting Dilution Coculture Assay
Abstract
Combination antiretroviral therapy (cART) can reduce HIV-1 viremia to clinically undetectable levels. However, replication competent virus persists in a long-lived latent reservoir in resting, memory CD4(+) T cells. The latent reservoir in resting CD4(+) T cells is the major barrier to curing HIV-1 infection. The recent case of the Berlin patient has suggested that it may be possible to cure HIV-1 infection in certain situations. As efforts to cure HIV-1 infection progress, it will become critical to measure the latent reservoir in patients participating in clinical trials of eradication strategies. Our laboratory has developed a limiting dilution virus outgrowth assay that can be used to demonstrate the presence and persistence of latent HIV-1 in patients. Here we describe both the original and a simplified version of the quantitative virus outgrowth assay (QVOA) to measure the frequency of latently infected resting CD4(+) T cells with replication competent provirus in patients on suppressive cART.
Keywords: HIV-1; Latency; Latent reservoir; Viral outgrowth assay.
Similar articles
-
Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.Annu Rev Immunol. 2000;18:665-708. doi: 10.1146/annurev.immunol.18.1.665. Annu Rev Immunol. 2000. PMID: 10837072 Review.
-
A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children.J Clin Invest. 2000 Apr;105(7):995-1003. doi: 10.1172/JCI9006. J Clin Invest. 2000. PMID: 10749578 Free PMC article.
-
In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection.Retrovirology. 2016 May 21;13(1):36. doi: 10.1186/s12977-016-0268-7. Retrovirology. 2016. PMID: 27206407 Free PMC article.
-
Therapeutic Approaches to Eradicate Latent HIV-1 in Resting CD4+ T Cells.Curr Top Med Chem. 2016;16(10):1191-7. doi: 10.2174/1568026615666150901114138. Curr Top Med Chem. 2016. PMID: 26324046 Review.
-
Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure.J Virol. 2002 Sep;76(18):9481-92. doi: 10.1128/jvi.76.18.9481-9492.2002. J Virol. 2002. PMID: 12186930 Free PMC article.
Cited by
-
The role of CD32 during HIV-1 infection.Nature. 2018 Sep;561(7723):E17-E19. doi: 10.1038/s41586-018-0494-3. Epub 2018 Sep 19. Nature. 2018. PMID: 30232425 Free PMC article.
-
New Frontiers in Measuring and Characterizing the HIV Reservoir.Front Microbiol. 2019 Dec 18;10:2878. doi: 10.3389/fmicb.2019.02878. eCollection 2019. Front Microbiol. 2019. PMID: 31921056 Free PMC article. Review.
-
The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy.J Clin Invest. 2023 Sep 1;133(17):e171554. doi: 10.1172/JCI171554. J Clin Invest. 2023. PMID: 37463049 Free PMC article.
-
Autologous IgG antibodies block outgrowth of a substantial but variable fraction of viruses in the latent reservoir for HIV-1.Proc Natl Acad Sci U S A. 2020 Dec 15;117(50):32066-32077. doi: 10.1073/pnas.2020617117. Epub 2020 Nov 25. Proc Natl Acad Sci U S A. 2020. PMID: 33239444 Free PMC article.
-
Distinct viral reservoirs in individuals with spontaneous control of HIV-1.Nature. 2020 Sep;585(7824):261-267. doi: 10.1038/s41586-020-2651-8. Epub 2020 Aug 26. Nature. 2020. PMID: 32848246 Free PMC article.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials